BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9362422)

  • 1. Mechanisms of bone lesions in multiple myeloma and lymphoma.
    Roodman GD
    Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
    Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
    Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an in vivo model of human multiple myeloma bone disease.
    Alsina M; Boyce B; Devlin RD; Anderson JL; Craig F; Mundy GR; Roodman GD
    Blood; 1996 Feb; 87(4):1495-501. PubMed ID: 8608240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the pathogenesis of osteolysis in multiple myeloma patients.
    Giuliani N; Colla S; Rizzoli V
    Acta Biomed; 2004 Dec; 75(3):143-52. PubMed ID: 15796087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-beta and hypercalcemia.
    Ishibashi K; Kodama M; Hanada S; Arima T
    Leuk Lymphoma; 1992 Aug; 7(5-6):409-17. PubMed ID: 1493442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy.
    Firkin F; Schneider H; Grill V
    Leuk Lymphoma; 1998 May; 29(5-6):499-506. PubMed ID: 9643563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma.
    Durie BG; Salmon SE; Mundy GR
    Br J Haematol; 1981 Jan; 47(1):21-30. PubMed ID: 7437344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone hyperresorption in multiple myeloma].
    Beaudreuil J; Orcel P
    Presse Med; 2000 Mar; 29(9):492-7. PubMed ID: 10745943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-dependent homotypic adhesion through leukocyte function-associated antigen-1/intracellular adhesion molecule-1 induces interleukin-1 and parathyroid hormone-related protein production on adult T-cell leukemia cells in vitro.
    Wake A; Tanaka Y; Nakatsuka K; Misago M; Oda S; Morimoto I; Eto S
    Blood; 1995 Sep; 86(6):2257-67. PubMed ID: 7662973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and pathophysiology of hypercalcemia.
    Mundy GR
    Calcif Tissue Int; 1990; 46 Suppl():S3-10. PubMed ID: 2105829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia.
    Okada Y; Tsukada J; Nakano K; Tonai S; Mine S; Tanaka Y
    J Bone Miner Res; 2004 Jul; 19(7):1105-11. PubMed ID: 15176993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone resorption associated with uncoupling of osteoclastic and osteoblastic activities in adult T cell leukemia with hypercalcemia: case report.
    Hino M; Yamane T; Ohta K; Shioi A; Koyama H; Tahara H; Nishizawa Y; Tatsumi N
    Ann Hematol; 2001 Jul; 80(7):426-9. PubMed ID: 11529470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteolytic bone resorption in adult T-cell leukemia/lymphoma.
    Shu ST; Martin CK; Thudi NK; Dirksen WP; Rosol TJ
    Leuk Lymphoma; 2010 Apr; 51(4):702-14. PubMed ID: 20214446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid-hormone-related peptide in hematologic malignancies.
    Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
    Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypercalcemia in a child with acute nonlymphocytic leukemia: the role of parathyroid hormone-related protein and proinflammatory cytokines.
    Kounami S; Yoshiyama M; Nakayama K; Hiramatsu C; Aoyagi N; Yoshikawa N
    Acta Haematol; 2004; 112(3):160-3. PubMed ID: 15345899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma.
    Tsujimura H; Nagamura F; Iseki T; Kanazawa S; Saisho H
    Am J Hematol; 1998 Oct; 59(2):168-70. PubMed ID: 9766803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma/hypercalcemia.
    Oyajobi BO
    Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S4. PubMed ID: 17634143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
    Cruz JC; Alsina M; Craig F; Yoneda T; Anderson JL; Dallas M; Roodman GD
    Exp Hematol; 2001 Apr; 29(4):441-7. PubMed ID: 11301184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.